Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138778 |
US |
2 | |
Hidradenitis, Arthralgia, White blood cell count increased, Neutrophil count increased, Blood glucose increased, Blood chloride increased, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 2 | 25139012 |
US |
66 | 1 |
Inappropriate antidiuretic hormone secretion, Cerebral haemorrhage, Intervertebral disc disorder, Seizure cluster, Scar, Feeling abnormal, Disturbance in attention, Skin fissures, Abnormal behaviour, Skin burning sensation, Cellulitis, Depressed mood, Blood glucose increased, Dry skin, Weight decreased, Liver disorder, Depression, Cerebral disorder, Initial insomnia, |
||||
DUPILUMAB, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, TIRZEPATIDE, ALBUTEROL SULFATE, ALPRAZOLAM, AMLODIPINE BESYLATE, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, INSULIN GLARGINE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ZONISAMIDE, MONTELUKAST, NEBIVOLOL HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SEMAGLUTIDE, PANTOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, BUPRENORPHINE, |
||||
| 3 | 25139095 |
US |
60 | 1 |
Blood glucose increased, Visual impairment, |
||||
INSULIN LISPRO, |
||||
| 4 | 25139269 |
US |
57 | 2 |
Blood glucose increased, Low density lipoprotein increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 5 | 25140407 |
US |
46 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 6 | 25140666 |
US |
45 | 1 |
Fall, Coma, Blood glucose decreased, Loss of consciousness, Blood glucose increased, Impaired gastric emptying, Illness, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 7 | 25140750 |
US |
78 | 1 |
Blood glucose increased, |
||||
GALCANEZUMAB-GNLM, |
||||
| 8 | 25141155 |
DE |
67 | 1 |
Pancytopenia, Blood glucose increased, Chronic kidney disease, Blood uric acid increased, C-reactive protein increased, Blood lactate dehydrogenase increased, Protein total, |
||||
PIRTOBRUTINIB, PIRTOBRUTINIB, PANTOPRAZOLE, CYCLOSPORINE, DIVALPROEX SODIUM, ATOVAQUONE, BISOPROLOL FUMARATE, AMLODIPINE, TIOTROPIUM BROMIDE, FLUCONAZOLE, |
||||
| 9 | 25141209 |
IN |
46 | 2 |
Death, Swelling face, Ecchymosis, Weight decreased, Pain, Tenderness, Rash, Blood triglycerides increased, Blood cholesterol increased, Blood glucose increased, Weight increased, Oedema, |
||||
LORLATINIB, LORLATINIB, LORLATINIB, ROSUVASTATIN CALCIUM, PREGABALIN, METHYLPREDNISOLONE, METHYLPREDNISOLONE, TORSEMIDE, TORSEMIDE, |
||||
| 10 | 25141398 |
US |
77 | 2 |
Renal impairment, Blood pressure decreased, Malaise, Blood glucose increased, Vision blurred, Weight increased, Headache, Decreased appetite, Diarrhoea, Cortisol decreased, |
||||
SPIRONOLACTONE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, EMPAGLIFLOZIN, |
||||
| 11 | 25141503 |
US |
67 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, HYDROCORTISONE, |
||||
| 12 | 25141675 |
US |
2 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLULISINE, INSULIN GLARGINE, |
||||
| 13 | 25142171 |
US |
1 | |
Drug ineffective, Blood glucose increased, |
||||
LINAGLIPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 14 | 25142286 |
US |
60 | 2 |
Product dose omission issue, Blood glucose increased, Dizziness, |
||||
INSULIN GLARGINE, |
||||
| 15 | 25142621 |
US |
62 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 16 | 25145421 |
77 | 1 | |
Unresponsive to stimuli, Oxygen saturation decreased, Vomiting, Blood glucose increased, Cardio-respiratory arrest, |
||||
LENALIDOMIDE, |
||||
| 17 | 25138407 |
US |
77 | 1 |
Dizziness, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 18 | 25138505 |
US |
63 | 2 |
Blood glucose increased, Accidental underdose, |
||||
INSULIN GLARGINE, |
||||
| 19 | 25137921 |
US |
36 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 20 | 25137952 |
US |
69 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 21 | 25137993 |
US |
37 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 22 | 25138044 |
US |
57 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 23 | 25132177 |
US |
||
Blood glucose increased, Device leakage, |
||||
EXENATIDE, |
||||
| 24 | 25132223 |
US |
41 | 1 |
Hunger, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 25 | 25132422 |
US |
75 | 2 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 26 | 25132472 |
US |
||
Blood glucose increased, |
||||
CAPIVASERTIB, |
||||
| 27 | 25132939 |
GB |
71 | 1 |
Blindness, Myocardial infarction, Abdominal discomfort, Malaise, Headache, Nausea, Diarrhoea, Hallucination, Malaise, COVID-19, Dizziness, Tinnitus, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Sleep terror, Transient ischaemic attack, Fatigue, Vomiting, Pericarditis, Cardiospasm, Dyspnoea, Atrial tachycardia, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Subarachnoid haemorrhage, Heart rate increased, Muscle twitching, Abdominal pain upper, Dehydration, Hyperhidrosis, Rash papular, Lip swelling, Pruritus, Palmoplantar keratoderma, Dry skin, Angioedema, Chest pain, Palpitations, Tachycardia, Off label use, Intentional product misuse, Pain, Anosmia, Eye pruritus, Facial pain, Abdominal discomfort, Carotid artery occlusion, Back pain, Adverse drug reaction, Abdominal pain upper, Blood glucose increased, Amnesia, Immunisation, Alopecia, Pyrexia, Tension headache, Migraine, Vasculitis, Intentional product use issue, Pruritus genital, Ventricular tachycardia, |
||||
BISOPROLOL FUMARATE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, NAPROXEN, NAPROXEN SODIUM, SIMVASTATIN, APIXABAN, AMITRIPTYLINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DAPAGLIFLOZIN, DIGOXIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, |
||||
| 28 | 25132963 |
CO |
84 | 1 |
Loss of consciousness, Weight decreased, Drug ineffective, Blood glucose increased, Blood glucose decreased, Blood pressure abnormal, Dizziness, Nausea, Asthenia, Visual impairment, |
||||
ORAL SEMAGLUTIDE, |
||||
| 29 | 25133432 |
US |
1 | |
Cerebrovascular accident, Influenza, Blood glucose decreased, Blood glucose increased, |
||||
INSULIN ASPART, |
||||
| 30 | 25133493 |
US |
20 | |
Blood glucose increased, Device issue, |
||||
INSULIN ASPART, |
||||
| 31 | 25133495 |
US |
2 | |
Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 32 | 25133908 |
US |
94 | 2 |
Blood glucose increased, Drug dose omission by device, Device mechanical issue, Wrong technique in device usage process, |
||||
INSULIN GLARGINE, |
||||
| 33 | 25133935 |
US |
75 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 34 | 25134099 |
US |
73 | 2 |
Bronchitis, Respiratory syncytial virus infection, Kidney infection, Blood glucose increased, Injection site erythema, Influenza, Cystitis, |
||||
DUPILUMAB, |
||||
| 35 | 25134540 |
US |
2 | |
Blood glucose increased, Back pain, Trigger finger, Arthralgia, Fall, Pain in extremity, Muscle spasms, Hypoaesthesia, Paraesthesia, Blood potassium decreased, Lipodystrophy acquired, |
||||
INSULIN LISPRO-AABC, |
||||
| 36 | 25134641 |
US |
70 | 2 |
Blood glucose increased, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 37 | 25134827 |
GB |
66 | 1 |
Blood glucose increased, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 38 | 25134863 |
JP |
7 | 2 |
Carcinoembryonic antigen increased, Glycosylated haemoglobin increased, Blood glucose increased, Blood creatine phosphokinase increased, Carbohydrate antigen 125 increased, Squamous cell carcinoma antigen increased, Blood bilirubin decreased, Carboxyhaemoglobin decreased, |
||||
CEMIPLIMAB-RWLC, CEMIPLIMAB-RWLC, |
||||
| 39 | 25134927 |
US |
2 | |
Blood glucose increased, Injection site pain, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 40 | 25135231 |
US |
60 | 1 |
Glomerular filtration rate decreased, Blood glucose increased, Blood urea increased, Blood creatinine increased, Protein urine present, Urinary occult blood positive, |
||||
SPARSENTAN, VITAMIN C, ERGOCALCIFEROL, INDAPAMIDE, LEVOTHYROXINE, SEMAGLUTIDE, |
||||
| 41 | 25135419 |
US |
46 | |
Blood glucose increased, Accidental underdose, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 42 | 25135823 |
US |
2 | |
Blood glucose increased, |
||||
| 43 | 25135888 |
JP |
2 | |
Loss of consciousness, Blood glucose increased, |
||||
ARIPIPRAZOLE, |
||||
| 44 | 25136051 |
US |
||
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 45 | 25136221 |
CN |
2 | |
Limb operation, Fall, Blood glucose increased, |
||||
| 46 | 25136260 |
PT |
65 | 2 |
Demyelinating polyneuropathy, Allodynia, Constipation, Abdominal distension, Pruritus, Skin burning sensation, Hypoglycaemia, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN ASPART, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 47 | 25136401 |
EG |
1 | |
Cardiac operation, Hypertension, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
INSULIN HUMAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SACUBITRIL AND VALSARTAN, |
||||
| 48 | 25136606 |
US |
||
Blood glucose increased, Frustration tolerance decreased, |
||||
DULAGLUTIDE, |
||||
| 49 | 25136868 |
CN |
65 | 2 |
Blood pressure increased, Product physical issue, Device issue, Cardiac discomfort, Blood glucose increased, |
||||
| 50 | 25137012 |
US |
59 | 2 |
Torsade de pointes, Ventricular fibrillation, Tachyarrhythmia, Long QT syndrome, Blood potassium decreased, Blood glucose increased, Anion gap increased, |
||||
TIRZEPATIDE, |
||||
| 51 | 25137026 |
US |
30 | 1 |
Myocardial infarction, Blood glucose increased, Wrong patient received product, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 52 | 25141656 |
|||
Drug ineffective, Weight increased, Glycosylated haemoglobin increased, Blood glucose increased, Metabolic disorder, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 53 | 25141662 |
|||
Drug ineffective, Metabolic disorder, Weight increased, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 54 | 25126293 |
US |
88 | 2 |
Feeling abnormal, Oxygen saturation decreased, Heart rate decreased, Asthenia, Dyspnoea, Blood glucose increased, Headache, Injection site bruising, Nausea, |
||||
EVOLOCUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 55 | 25126609 |
US |
54 | 2 |
Pain in extremity, Blood glucose increased, Injection site erythema, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 56 | 25126758 |
US |
57 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 57 | 25127456 |
PR |
79 | 1 |
Cerebrovascular accident, Disorientation, Headache, Aggression, Blood glucose increased, |
||||
RISANKIZUMAB-RZAA, |
||||
| 58 | 25127471 |
US |
52 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO-AABC, |
||||
| 59 | 25127733 |
US |
54 | 1 |
Blood glucose increased, Blood glucose decreased, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 60 | 25127846 |
CN |
80 | 2 |
Blood pressure increased, Lipids increased, Diarrhoea, Blood glucose increased, Hypersensitivity, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 61 | 25127888 |
US |
75 | |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 62 | 25127987 |
US |
||
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 63 | 25128025 |
US |
70 | 2 |
Loss of consciousness, Blood glucose decreased, Product prescribing issue, Blood glucose increased, |
||||
INSULIN ASPART, INSULIN ASPART, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 64 | 25128271 |
US |
74 | 2 |
Blood ketone body increased, Blood glucose increased, Product quality issue, Headache, Nausea, |
||||
INSULIN ASPART, |
||||
| 65 | 25128623 |
US |
69 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 66 | 25128702 |
US |
83 | 2 |
Blood glucose increased, Device mechanical issue, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 67 | 25129116 |
US |
83 | 1 |
Condition aggravated, Blood pressure increased, Blood glucose increased, Contraindicated product administered, |
||||
SACUBITRIL AND VALSARTAN, SPIRONOLACTONE, CARVEDILOL, LEVOTHYROXINE, |
||||
| 68 | 25129342 |
US |
53 | 1 |
Feeling cold, Blood glucose increased, Drug ineffective, Respiration abnormal, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 69 | 25129716 |
US |
67 | 2 |
Injection site haemorrhage, Injection site pain, Device issue, Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 70 | 25130915 |
US |
2 | |
Blood glucose increased, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 71 | 25131490 |
US |
||
Blood glucose increased, Diabetes mellitus inadequate control, |
||||
| 72 | 25131559 |
US |
58 | 1 |
Blood glucose increased, Visual impairment, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 73 | 25131583 |
US |
85 | 1 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 74 | 25132017 |
US |
51 | |
Blood glucose increased, Frustration tolerance decreased, Stress, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN ASPART, |
||||
| 75 | 25121153 |
US |
2 | |
Fatigue, Blood cholesterol increased, Decreased appetite, Blood glucose increased, Tremor, Hyperhidrosis, Chills, Hot flush, Bone pain, Headache, Gait disturbance, |
||||
ROSUVASTATIN, ANASTROZOLE, ANASTROZOLE TABLETS, PALBOCICLIB, |
||||
| 76 | 25121479 |
GB |
||
Blood glucose increased, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 77 | 25121577 |
US |
72 | 1 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN GLARGINE, |
||||
| 78 | 25121781 |
US |
||
Oral herpes, Toothache, Abdominal pain upper, Blood glucose increased, Headache, |
||||
RELUGOLIX, RELUGOLIX, APALUTAMIDE, GLIPIZIDE, EMPAGLIFLOZIN, LOSARTAN, NATEGLINIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DULAGLUTIDE, |
||||
| 79 | 25121870 |
US |
2 | |
Blood glucose increased, Abdominal discomfort, Pain, Nausea, |
||||
EVOLOCUMAB, |
||||
| 80 | 25122108 |
BR |
44 | 1 |
Loss of consciousness, Syncope, Wrong technique in product usage process, Blood glucose increased, Malaise, Product administration interrupted, Product formulation issue, Anxiety, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 81 | 25122790 |
US |
62 | 2 |
Blood glucose increased, Injection site pain, Injection site coldness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 82 | 25123362 |
US |
1 | |
Blood glucose increased, Blood pressure increased, |
||||
LOSARTAN POTASSIUM, LOSARTAN, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, GUAIFENESIN, |
||||
| 83 | 25123985 |
CN |
72 | 2 |
Musculoskeletal disorder, Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 84 | 25124028 |
US |
74 | 1 |
Blood glucose increased, Drug dose omission by device, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 85 | 25124119 |
US |
5 | 2 |
Fournier^s gangrene, Blood glucose increased, Obesity, Glycosylated haemoglobin increased, |
||||
EMPAGLIFLOZIN, |
||||
| 86 | 25124159 |
US |
43 | 1 |
Blood glucose increased, Product quality issue, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 87 | 25124229 |
US |
84 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 88 | 25124759 |
US |
60 | 1 |
Blood glucose increased, Visual impairment, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 89 | 25124780 |
US |
35 | 2 |
Blood glucose increased, Headache, Nausea, Fatigue, |
||||
INSULIN LISPRO, |
||||
| 90 | 25124976 |
US |
2 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
| 91 | 25124977 |
US |
48 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 92 | 25125085 |
US |
||
Knee arthroplasty, Pain, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 93 | 25125096 |
US |
77 | 1 |
Glycosylated haemoglobin increased, Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 94 | 25125418 |
US |
||
Pneumonia, Bronchitis, Atrial fibrillation, Blood glucose increased, Viral infection, Asthma, |
||||
MEPOLIZUMAB, PREDNISONE, GABAPENTIN, LISINOPRIL, HYDROCHLOROTHIAZIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 95 | 25125741 |
US |
73 | 1 |
Glycosylated haemoglobin increased, Blood glucose increased, Incorrect dose administered, Retinal disorder, Vision blurred, Bowel movement irregularity, Gastrointestinal disorder, Cough, Malaise, |
||||
INSULIN LISPRO, INSULIN LISPRO, SEMAGLUTIDE, LIRAGLUTIDE, INSULIN GLARGINE, |
||||
| 96 | 25125743 |
US |
||
Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 97 | 25126067 |
US |
49 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 98 | 25115805 |
US |
76 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 99 | 25116158 |
US |
||
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 100 | 25116256 |
US |
6 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28